carvedilol has been researched along with Hematologic Malignancies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jhorawat, R | 1 |
| Kumari, S | 1 |
| Varma, SC | 1 |
| Rohit, MK | 1 |
| Narula, N | 1 |
| Suri, V | 1 |
| Malhotra, P | 1 |
| Jain, S | 1 |
| Smiseth, OA | 1 |
| Edvardsen, T | 1 |
| Skulstad, H | 1 |
| Bosch, X | 1 |
| Rovira, M | 1 |
| Sitges, M | 1 |
| Domènech, A | 1 |
| Ortiz-Pérez, JT | 1 |
| de Caralt, TM | 1 |
| Morales-Ruiz, M | 1 |
| Perea, RJ | 1 |
| Monzó, M | 1 |
| Esteve, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Left Ventricular Dysfunction With Enalapril and Carvedilol in Patients Submitted to Intensive Chemotherapy for the Treatment of Malignant Hemopathies[NCT01110824] | Phase 3 | 90 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carvedilol and Hematologic Malignancies
| Article | Year |
|---|---|
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted t
Topics: Adult; Antineoplastic Agents; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Adminis | 2013 |
2 other studies available for carvedilol and Hematologic Malignancies
| Article | Year |
|---|---|
Preventive role of carvedilol in adriamycin-induced cardiomyopathy.
Topics: Aged; Carbazoles; Cardiomyopathies; Carvedilol; Doxorubicin; Echocardiography; Female; Heart Failure | 2016 |
Cardioprotection during chemotherapy: need for faster transfer of knowledge from cardiology to oncology and role for a cardio-oncologist.
Topics: Antineoplastic Agents; Carbazoles; Carvedilol; Enalapril; Female; Hematologic Neoplasms; Humans; Mal | 2013 |